Skip to main content
Bryan Supran

Bryan Supran

Bryan brings considerable corporate, strategic and business development experience from over 25 years as a leading corporate and transactional attorney across consumer healthcare, pharmaceutical and life sciences.

Since 2015, Bryan has served as Senior Vice President & Deputy General Counsel of Pfizer, a role that includes counselling management and the Board of Directors on strategic initiatives and business development transactions, such as Pfizer’s COVID-19 vaccine collaboration with BioNTech, the successful split-off of its animal health business as Zoetis, and the joint venture with GSK to create the premier global consumer healthcare business - now Haleon. Bryan served on the joint venture Board with GSK following the transaction with Pfizer until the demerger of Haleon.

Bryan’s role also has included leadership of Pfizer’s intellectual property and international legal teams, as well as legal support for Pfizer’s R&D and manufacturing organizations. Previously, Bryan practiced law at Ropes & Gray LLP in Boston and New York, where he helped establish the firm’s life sciences practice.

Favourite Haleon brand and reason: I love to travel and Emergen-C keeps my immune health strong while I’m on the move.